Prevalence, clinical characteristics, and pharmacologic treatment of Parkinson's disease in residents in long-term care facilities

Pharmacotherapy

Volumn 19, Issue 11 I, 1999, Pages 1321-1327

  Lapane, Kate L ^a,c   Fernandez, Hubert H ^a,b   Friedman, Joseph H ^a,b  

^a BROWN UNIVERSITY   (United States)

^b MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; ANTIPARKINSON AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; DOPAMINE RECEPTOR STIMULATING AGENT; HALOPERIDOL; LEVODOPA; NEUROLEPTIC AGENT; PHENOTHIAZINE; RISPERIDONE; SELEGILINE; TIOTIXENE;

ARTICLE; CLINICAL FEATURE; COGNITION; DATA BASE; DISEASE SEVERITY; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NURSING HOME; PARKINSON DISEASE;

EID: 0032726757     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.19.16.1321.30877     Document Type: Article

References (38)

1. Mutch WJ, Dingwall-Fordyce I, Downie AW, et al. Parkinson's disease in a Scottish city. Br Med J 1986;292:534-6.
2. Fall PA, Arelson O, Fredrikson M, et al. Age-standardized incidence and prevalence of Parkinson's disease in a Swedish community. J Clin Epidemiol 1996;49:637-41.
3. Tison F, Dartiques JF, Dube L, et al. Prevalence of Parkinson's disease in the elderly. A population study in Gironde, France. Acta Neurol Scand 1994;90:111-15.
4. Larsen JP. Parkinson's disease as a community health problem: study in Norwegian nursing homes. BMJ 1991;303:741-3.
5. Mitchell SL, Kiely DK, Kiel DP, Lipsitz LA. The epidemiology, clinical characteristics and natural history of older nursing home residents with a diagnosis of Parkinson's disease. J Am Geriatr Soc 1996;44:394-9.
6. Goetz CG, Stebbins GT. Mortality and hallucinations in nursing home patients with advanced Parkinson's disease. Neurology 1995;45:669-71.
7. Liu K, Manton KG. The characteristics and utilization pattern of an admission cohort of nursing home patients. Gerontologist 1983;23:92-8.
8. Lazenby HC, Letch SW. National health expenditures 1989. Health Care Financing Rev 1990;12:1-26.
9. Morris JN, Hawes C, Fries BE, et al. Designing the national resident assessment instrument for nursing homes. Gerontologist 1990;30:293-7.
10. Bernabei R, Gambassi G, Mor V. The SAGE database: introducing functional outcomes in geriatric pharmaco-epidemiology. J Am Geriatr Soc 1998;46:250-2.
11. Bernabei R, Gambassi G, Lapane K, et al. Principal characteristics of the SAGE database: a new resource for research on outcomes in long-term care. J Gerontol 1999;54A:M25-33.
12. Gambassi G, Landi F, Peng L, et al. Validity of diagnostic and drug data in standardized nursing home resident assessments: potential for geriatric pharmacoepidemiology. Med Care 1998;36(2):22-34.
13. Morris JN, Fries BE, Mehr DR, et al. MDS cognitive performance scale. J Gerontol 1994;49:M174-82.
14. Mor V, Branco K, Fleishman J, et al. The structure of social engagement among nursing home residents. J Gerontol 1995;50:P1-8.
15. Anonymous. Minimum data set plus training manual. Natick, MA: Eliot Press, 1991.
16. Hawes C, Morris JN, Phillips CD, Mor V, Fries BE, Nonemaker S. Reliability estimates for the Minimum Data Set for nursing home resident assessment and care screening (MDS). Gerontologist 1995;2:172-8.
17. Hartmaier SL, Sloane PD, Guess HA, et al. The MDS cognition scale: a valid instrument for identifying and staging nursing home residents with dementia using the minimum data set. J Am Geriatr Soc 1994;42:1173-9.
18. Hartmaier SL, Sloane PD, Guess HA, et al. Validation of the minimum data set cognitive performance scale: agreement with the mini mental state examination. J Gerontol Biol Sci Med 1995;50:M128-33.
19. Rockwood K, Stolee P, McDowell I. Factors associated with institutionalization of older people in Canada: testing a multifactorial definition of frailty. J Am Geriatr Soc 1996;44:578-82.
20. Caine ED, Lyness JM, King DA. Reconsidering depression in the elderly. Am J Geriatr Psychol 1993;1:4-20.
21. Kalayam B, Shamoian CA. Geriatric psychiatry: an update. J Clin Psychiatry 1990;51(5):177-83.
22. Lieberman A. Managing the neuropsychiatric symptoms of Parkinson's disease. Neurology 1998;59(6):s33-8.
23. Tom T, Cummings JL. Depression in Parkinson's disease. Pharmacological characteristics and treatment. Drugs Aging 1998;12:55-74.
24. Friedman JH. The management of levodopa psychoses. Clin Neuropharmacol 1991;14(4):283-95.
25. Factor SA, Molho ES, Podskalny GD, Brown D. Parkinson's disease: drug-induced psychiatric states. In: Weiner W, Lang AE, eds. Advances in neurology, vol 65, New York: Raven Press, 1995:115-38.
26. The Parkinson Study Group. Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease. N Engl J Med 1999;340:757-63.
27. Tison F, Lecaroz J, Letenneur L, Dartigues JF. Parkinsonism and exposure to neuroleptic drugs in elderly people living in institutions. Clin Neuropharmacol 1999;22:5-10.
28. Lieberman A, Dziatolowski M, Kupersmith M. Dementia in Parkinson's disease. Ann Neurol 1979;6:355-9.
29. Celesia GC, Barr AN. Psychosis and psychiatric manifestations of levodopa therapy. Arch Neurol 1970;23:193-200.
30. Poewe W, Granata R. Pharmacological treatment of PD. In: Watts RL, Koller WC, eds.Movement disorders: principles and practice. New York: McGraw-Hill, 1997:201-20.
31. Escarce JJ, Epstein KR, Colby DC, Schwartz JS. Racial differences in the elderly's use of medical procedures and diagnostic tests. Am J Public Health 1993;83:948-54.
32. Peterson ED, Wright SM, Daley J, Thibault GE. Racial variation in cardiac procedure use and survival following acute myocardial infarction in the Department of Veteran Affairs. JAMA 1994;271:1175-80.
33. Whittle J, Conigliaro J, Good CB, Lofgren RP. Racial differences in the use of invasive cardiovascular procedures in the Department of Veteran Affairs medical system. N Engl J Med 1993;329:621-7.
34. Schoenberg BS, Anderson DW, Haerer AF. Prevalence of Parkinson's disease in the biracial population of Copiah Country, Mississippi. Neurology 1988;35:841-5.
35. Mayeux R, Marder K, Cote LJ, et al. The frequency of idiopathic Parkinson's disease by age, ethnic group and sex in northern Manhattan, 1988-1993. Am J Epidemiol 1994;142:820-7.
36. Mayeux R, Denaro J, Hemenegildo N, et al. A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender. Arch Neurol 1992;49:492-7.
37. Paddison RM, Griffith RP. Occurrence of Parkinson's disease in the black patients at Charity Hospital in New Orleans. Neurology 1974;24:688-90.
38. Kessler II. Epidemiologic studies of Parkinson's disease: a hospital-based survey. Am J Epidemiol 1972;95:308-18.